July 13 - 17, 2026, 2-3 hours each day. Exact times TBD but all sessions will be between 1pm - 5pm Register here Open to Postdocs, Clinical Fellows/Residents, and Graduate Students Lead by Michelle Arkin, PhD, Michael Cheng, MD, and Trever Bivona, MD/PhD This workshop will provide training and a rigorous foundation for hypothesis-driven patient-focused research, covering clinical and preclinical iteration. Attendees will participate in interactive didactic and individualized discussions that culminate in a translational and/or clinical research protocol synopsis focused on testing a patient-centered hypothesis of their interest(s). For most topics, participants will first view online lectures, followed by in-person, small group discussion. Participants must be able to participate in the in-person group discussions to join the course. Open to postdocs, graduate students, senior clinical fellows and early career faculty. Learning Objectives: Summarize the stages of preclinical foundationsDescribe preclinical and clinical combination studies and when to use themSummarize clinical trial designExplain radionuclide therapiesExplain biomarkers and pharmacodynamic studiesDiscuss preclinical to clinical PK & PDSchedule: Monday 7/13: Preclinical Foundations & Case Studies Discussion Group – Michelle Arkin, PhDClass Project IntroductionTuesday 7/14: Synopsis of Clinical Trial Design – Andrew Ko, MD, FASCONuclear Medicine for Cancer Treatment Discussion Group - Michael Evans, PhDWednesday 7/15: Preclinical to Clinical PK & PD – Liang.Zhao, PhTBDThursday 7/16: Pre-Clinical Combination Therapies Discussion Group – Cathy Smith, MDClinical Combination Studies – Michael Cheng, MDClass project workFriday 7/17: Project presentations